Market revenue in 2023 | USD 522.5 million |
Market revenue in 2030 | USD 672.0 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Routine and special chemistry |
Fastest growing segment | Routine and Special Chemistry |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Routine and Special Chemistry |
Key market players worldwide | Abbott Laboratories, Danaher Corp, Roche Holding AG ADR, BD, EKF Diagnostics Holdings PLC, BioMerieux SA, Siemens Healthineers AG ADR, Bayer AG, Chembio Diagnostic Systems Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to critical care diagnostics market will help companies and investors design strategic landscapes.
Routine and special chemistry was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America critical care diagnostics market based on routine and special chemistry covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America critical care diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America critical care diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account